Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Approximately 26-32% of the iv dose of PF-06282999 is excreted in the unchanged form in rat
InChiKey: YRWLZFXJFBZBEY-UHFFFAOYSA-N
InChi: InChI=1S/C18H19NOS
15R)-2-[(2R
Cefpodoxime (free acid) Size:Contact [email protected] for quotation Approximately 26-32% of the ivCefpodoxime, as known as R 3763, is a metabolite of cefpodoxime proxetil. It is demonstrated that cefpodoxime, as an oral third generation cephalosporin antibiotic, is active against most Gram positive and Gram negative bacteria. Cefpodoxime suppresses bacterial septum and cell wall synthesis by binding to penicillin binding proteins (PBPs) located in the bacterial cytoplasmic membrane. In vitro: Cefpodoxime showed antibacterial activities against